PEAK6
UTHR icon

PEAK6’s United Therapeutics UTHR Stock Holding History

PEAK6’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Buy
+10,000
New +$4.98M 0.01% 812

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PEAK6's UTHR Position: Q1 2026 in Review

PEAK6 opened a new position in United Therapeutics (UTHR) in Q1 2026: 2 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #2585 among its holdings.

850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • PEAK6 held 2 shares of United Therapeutics worth $1.19K as of Q1 2026.
  • United Therapeutics was a new PEAK6 position in Q1 2026.
  • United Therapeutics made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #2585 holding.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.